| MeSH term | MeSH ID | Detail |
|---|---|---|
| Peri-Implantitis | D057873 | 1 associated lipids |
| Plaque, Atherosclerotic | D058226 | 7 associated lipids |
| Peripheral Arterial Disease | D058729 | 7 associated lipids |
| Osteoporotic Fractures | D058866 | 1 associated lipids |
| Bisphosphonate-Associated Osteonecrosis of the Jaw | D059266 | 1 associated lipids |
| Angina, Stable | D060050 | 2 associated lipids |
| Vascular Calcification | D061205 | 1 associated lipids |
| Atrial Remodeling | D064752 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:25266469 | ||||
| pmid:25264005 | ||||
| pmid:27394662 | ||||
| pmid:27377060 | ||||
| pmid:27307249 | ||||
| pmid:27301430 | ||||
| pmid:25056244 | ||||
| pmid:25055746 | ||||
| pmid:26983475 | ||||
| pmid:26982319 | ||||
| pmid:24810471 | ||||
| pmid:26744072 | ||||
| pmid:24440515 | ||||
| pmid:24439762 | ||||
| pmid:26452150 | ||||
| pmid:23701481 | ||||
| pmid:23594090 | ||||
| pmid:26196203 | ||||
| pmid:26190158 | ||||
| pmid:25953955 | ||||
| pmid:25944420 | ||||
| pmid:25934570 | ||||
| pmid:28576140 | ||||
| pmid:28556971 | ||||
| pmid:25744169 | ||||
| pmid:25741581 | ||||
| pmid:28044198 | ||||
| pmid:28041995 | ||||
| pmid:25494659 | ||||
| pmid:27163932 | ||||
| pmid:27684563 | ||||
| pmid:28593808 | ||||
| pmid:28577080 | ||||
| pmid:28567553 | ||||
| pmid:12354528 | ||||
| Park MK et al. | Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. | 2014 | pmid:24782183 | |
| pmid: | ||||
| Wang B et al. | Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. | 2014 | pmid:24431282 | |
| Yokota K et al. | Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. | 2014 | pmid:24431283 | |
| Gorczynski RM et al. | Neutral buoyancy and sleep-deprived serum factors alter expression of cytokines regulating osteogenesis. | 2005 May-Jun | Acta Astronaut | pmid:15835039 |
| Wang Y et al. | Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. | 2012 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:22427460 |
| Fei Q et al. | Osteogenic growth peptide enhances the proliferation of bone marrow mesenchymal stem cells from osteoprotegerin-deficient mice by CDK2/cyclin A. | 2010 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:20926513 |
| Xiao HL et al. | Expression and identification of mutated osteoprotegerin in culture cells and larvae of silkworm. | 2004 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:15156274 |
| Capuccini C et al. | Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. | 2008 | Acta Biomater | pmid:18554996 |
| Galli C et al. | Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. | 2012 | Acta Biomater | pmid:22564787 |
| Ruckh TT et al. | Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds. | 2010 | Acta Biomater | pmid:20144747 |
| Giuliani N et al. | Update on the pathogenesis of osteolysis in multiple myeloma patients. | 2004 | Acta Biomed | pmid:15796087 |
| Vaccarezza M et al. | A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes. | 2007 | Acta Biomed | pmid:17465340 |
| Ren MY et al. | Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome. | 2008 | Acta Cardiol | pmid:19014006 |
| Gallo J et al. | [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. | 2010 | Acta Chir Orthop Traumatol Cech | pmid:21040654 |
| Singh DK et al. | Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus. | 2010 | Acta Diabetol | pmid:19784545 |
| Jung CH et al. | The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM. | 2010 | Acta Diabetol | pmid:19787288 |
| Nicolin V and Narducci P | Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231. | 2010 | Acta Histochem. | pmid:19058836 |
| Hidayat R et al. | Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. | 2014 | Acta Med Indones | pmid:24760805 |
| Ghorbanihaghjo A et al. | Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. | 2014 | Acta Med Iran | pmid:24901855 |
| Naumann U et al. | Expression and functional activity of osteoprotegerin in human malignant gliomas. | 2004 | Acta Neuropathol. | pmid:14504888 |
| Hofbauer LC et al. | Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid. | 2004 | Acta Neuropathol. | pmid:15106011 |
| Verde ME et al. | Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. | 2015 | Acta Odontol Latinoam | pmid:27095621 |
| Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
| Mountzios G et al. | Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton. | 2007 | Acta Oncol | pmid:17453373 |
| Folestad A et al. | Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. | 2015 | Acta Orthop | pmid:25811776 |
| Baumann B et al. | Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. | 2004 | Acta Orthop Scand | pmid:15260421 |
| Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
| Wang L et al. | Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. | 2010 | Acta Pharmacol. Sin. | pmid:20208552 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| Li YQ et al. | Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. | 2012 | Acta Pharmacol. Sin. | pmid:22120966 |
| Hou L et al. | Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. | 2011 | Acta Vet. Scand. | pmid:21435269 |
| Suliman ME et al. | Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. | 2008 | Adv Clin Chem | pmid:19004191 |
| Weissen-Plenz G et al. | Mechanisms of arterial calcification: spotlight on the inhibitors. | 2008 | Adv Clin Chem | pmid:19004192 |
| Naumnik B et al. | Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. | 2013 | Adv Med Sci | pmid:23959668 |
| Gajewska J et al. | Osteoprotegerin and C-telopeptide of type I collagen in Polish healthy children and adolescents. | 2006 | Adv Med Sci | pmid:17357324 |
| Ambroszkiewicz J et al. | Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. | 2013 | Adv Med Sci | pmid:24277958 |
| Grzegorzewska AE and Mlot-Michalska M | Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone. | 2006 | Adv Perit Dial | pmid:16983970 |
| Grzegorzewska AE and MÅ‚ot-Michalska M | Serum level of intact parathyroid hormone and other markers of bone metabolism in dialyzed patients. | 2007 | Adv Perit Dial | pmid:17886625 |
| Mesquita M et al. | Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. | 2005 | Adv Perit Dial | pmid:16686314 |
| Grzegorzewska AE and Mlot M | Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. | 2005 | Adv Perit Dial | pmid:16686316 |
| Wagner TU et al. | The teleost fish medaka (Oryzias latipes) as genetic model to study gravity dependent bone homeostasis in vivo. | 2003 | Adv Space Res | pmid:15000082 |
| Anandarajah AP and Schwarz EM | Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731622 |
| Leibbrandt A and Penninger JM | RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731623 |
| Hikita A and Tanaka S | Ectodomain shedding of receptor activator of NF-kappaB ligand. | 2007 | Adv. Exp. Med. Biol. | pmid:17966383 |
| Hu Y et al. | Layer-by-layer assembly of β-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis. | 2010 | Adv. Mater. Weinheim | pmid:20717987 |
| McKenna MJ and Kristiansen AG | Molecular biology of otosclerosis. | 2007 | Adv. Otorhinolaryngol. | pmid:17245026 |
| Prigione A and Cortopassi G | Mitochondrial DNA deletions induce the adenosine monophosphate-activated protein kinase energy stress pathway and result in decreased secretion of some proteins. | 2007 | Aging Cell | pmid:17651460 |
| Tarantino U et al. | A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. | 2013 | Aging Clin Exp Res | pmid:24046047 |
| Mora S et al. | Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents. | 2007 | AIDS | pmid:17502723 |
| MartÃnez E et al. | Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. | 2012 | AIDS | pmid:23018438 |
| Pan G et al. | Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. | 2006 | AIDS Res. Hum. Retroviruses | pmid:17147500 |
| Kelesidis T et al. | Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. | 2013 | AIDS Res. Hum. Retroviruses | pmid:23351153 |
| Kelesidis T et al. | Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. | 2014 Jul-Sep | AIDS Rev | pmid:25102334 |
| Allen CA et al. | Bilateral cavernous internal carotid aneurysms in a child with juvenile paget disease and osteoprotegerin deficiency. | 2008 | AJNR Am J Neuroradiol | pmid:17947367 |
| GarcÃa-Valdecasas-Campelo E et al. | Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. | 2006 May-Jun | Alcohol Alcohol. | pmid:16476762 |
| McCormick RK | Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. | 2007 | Altern Med Rev | pmid:17604458 |
| Han G et al. | Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. | 2010 | Am J Orthod Dentofacial Orthop | pmid:21055594 |
| Li F et al. | Effect of parathyroid hormone on experimental tooth movement in rats. | 2013 | Am J Orthod Dentofacial Orthop | pmid:24075660 |
| Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
| Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
| Kuang B et al. | Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273362 |
| Flórez-Moreno GA et al. | Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273364 |
| Galli C et al. | Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22640672 |